Glenn P.  Muir net worth and biography

Glenn Muir Biography and Net Worth

Director of Neuronetics

Glenn P. Muir, a certified public accountant, has extensive experience in finance and financial reporting. Glenn was Hologic’s Chief Financial Officer from 1992 to May 2014 and its only Executive Vice President since 2000 with a broad range of operating responsibilities including the key architect in the formulation and implementation of the Company’s strategic initiatives.

While at Hologic for over 25 years Glenn was at the helm of the Company’s IPO in 1990 when it was a single-product single-disease niche medical product company and continuing to the leader it is today in women’s health. Hologic has grown and evolved to a provider of advanced technologies that make a difference in people’s lives with operations around the world, revenues of over $2.5 billion, an enterprise value exceeding $10 billion and over 6,000 employees.
Glenn has steered two companies through IPO’s (and numerous follow-on offerings), built world-class organizations, raised over $5 billion in debt and led the acquisition/integration of over twenty companies. His industry experience is specific to the healthcare industry and includes medical imaging, diagnostics and surgical solutions.

Currently a member of the Board of Directors and the Audit Committee Chair at Repligen Corporation (Nasdaq: RGEN – http://www.repligen.com/), ReWalk Robotics Ltd (Nasdaq: RWLK – http://rewalk.com/) and G1 Therapeutics, Inc. (http://www.g1therapeutics.com/). His past Board of Director experience also includes RainDance Technologies, Inc. from 2014 until its acquisition by Bio-Rad Laboratories in February 2017, Hologic, Inc. (Nasdaq: HOLX) from 2001 to 2013 and Vivid Technologies, Inc. (Nasdaq: VVID) from 1996 until the Company was sold to EG&G in 1999.

Glenn graduated from the University of Massachusetts in Amherst where he was Treasurer and Board Member of the UMass Student Federal Credit Union. He has two graduate degrees: a Master in Business Administration from Harvard University Graduate School of Business Administration (full-time) and a Master in Science in Taxation from Bentley College Graduate School of Business (part-time). One of 2009 America’s Best CFOs as surveyed by Institutional Investor. Boston Business Journals 2011 CFO of the year. Member of the American Institute of Certified Public Accountants and the Massachusetts Society of Certified Public Accountants. Glenn lives in Lexington, Massachusetts with his wife and three children. With his family he enjoys the BVI, skiing, bridge and the Boy Scouts.

What is Glenn P. Muir's net worth?

The estimated net worth of Glenn P. Muir is at least $420.24 thousand as of September 5th, 2024. Muir owns 289,818 shares of Neuronetics stock worth more than $420,236 as of December 4th. This net worth evaluation does not reflect any other assets that Muir may own. Learn More about Glenn P. Muir's net worth.

How do I contact Glenn P. Muir?

The corporate mailing address for Muir and other Neuronetics executives is 3222 PHOENIXVILLE PIKE, MALVERN PA, 19355. Neuronetics can also be reached via phone at (610) 640-4202 and via email at [email protected]. Learn More on Glenn P. Muir's contact information.

Has Glenn P. Muir been buying or selling shares of Neuronetics?

Glenn P. Muir has not been actively trading shares of Neuronetics during the last ninety days. Most recently, on Thursday, September 5th, Glenn P. Muir bought 25,000 shares of Neuronetics stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $20,000.00. Following the completion of the transaction, the director now directly owns 289,818 shares of the company's stock, valued at $231,854.40. Learn More on Glenn P. Muir's trading history.

Who are Neuronetics' active insiders?

Neuronetics' insider roster includes Robert Cascella (Director), Sheryl Conley (Director), Stephen Furlong (CFO), Gregory Harper (VP), William Macan (VP), Glenn Muir (Director), Bruce Shook (Director), and Keith Sullivan (CEO). Learn More on Neuronetics' active insiders.

Are insiders buying or selling shares of Neuronetics?

In the last twelve months, insiders at the sold shares 9 times. They sold a total of 293,829 shares worth more than $1,185,003.13. The most recent insider tranaction occured on May, 12th when EVP Stephen Furlong sold 193,460 shares worth more than $826,074.20. Insiders at Neuronetics own 8.7% of the company. Learn More about insider trades at Neuronetics.

Information on this page was last updated on 5/12/2025.

Glenn P. Muir Insider Trading History at Neuronetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/5/2024Buy25,000$0.80$20,000.00289,818View SEC Filing Icon  
8/28/2024Buy12,776$0.85$10,859.60252,594View SEC Filing Icon  
See Full Table

Glenn P. Muir Buying and Selling Activity at Neuronetics

This chart shows Glenn P Muir's buying and selling at Neuronetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Neuronetics Company Overview

Neuronetics logo
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Read More

Today's Range

Now: $1.45
Low: $1.32
High: $1.51

50 Day Range

MA: $2.35
Low: $1.27
High: $3.12

2 Week Range

Now: $1.45
Low: $1.00
High: $5.92

Volume

858,265 shs

Average Volume

2,146,541 shs

Market Capitalization

$99.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71